Show simple item record

Access to CRISPR Genome Editing Technologies: Patents, Human Rights and the Public Interest

dc.contributor.authorMATTHEWS, Den_US
dc.contributor.editorCorrea, CMen_US
dc.contributor.editorHilty, RMen_US
dc.date.accessioned2021-11-09T09:05:22Z
dc.date.issued2021-10-06en_US
dc.identifier.isbn3030831167en_US
dc.identifier.isbn9783030831165en_US
dc.identifier.other4
dc.identifier.other4en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/75098
dc.description.abstractThis open access book is the outcome of a Global Forum on Innovation, Intellectual Property and Access to Medicines held in December 2019 at the Max Planck Instititute in Munich, organised by the South Centre and the Max Planck Institute.en_US
dc.format.extent105 - 133 (29)en_US
dc.publisherSpringer Nature AGen_US
dc.relation.ispartofAccess to Medicines and Vaccines Implementing Flexibilities Under Intellectual Property Lawen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectLawen_US
dc.subjectCRISPRen_US
dc.subjectGenome Editingen_US
dc.subjectPatentsen_US
dc.subjectHuman Rightsen_US
dc.subjectAccessen_US
dc.titleAccess to CRISPR Genome Editing Technologies: Patents, Human Rights and the Public Interesten_US
dc.typeBook chapter
dc.identifier.doi10.1007/978-3-030-83114-1en_US
pubs.notesNot knownen_US
pubs.place-of-publicationCham, Switzerlanden_US
pubs.publication-statusPublisheden_US
pubs.publisher-urlhttps://link.springer.com/book/10.1007/978-3-030-83114-1?sap-outbound-id=A045877815C4B5F672E68610EB863F6A7ED59AE9#tocen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution 3.0 United States
Except where otherwise noted, this item's license is described as Attribution 3.0 United States